Back to The Fusion: Mitofusin-2 in Alzheimer's Disease

Giulia Sita1, Patrizia Hrelia1, Agnese Graziosi1

  • 1Department of Pharmacy and BioTechnology, Alma Mater Studiorum-University of Bologna, via Irnerio 48, 40126 Bologna, Italy.

Insights

Mitofusin 2 (Mfn2) protein is crucial for mitochondrial dynamics and endoplasmic reticulum communication. Its role in Alzheimer's disease (AD) pathogenesis offers potential therapeutic targets for mitochondrial dysfunction disorders.

Area of Science:

  • Cell Biology
  • Neuroscience
  • Biochemistry

Background:

  • Mitochondria are essential dynamic organelles involved in cellular energy production.
  • Mitochondrial dysfunction is implicated in neurodegenerative diseases like Alzheimer's disease (AD).
  • Mitochondrial dynamics, including fission and fusion, are critical for maintaining organelle function.

Purpose of the Study:

  • To review the role of Mitofusin 2 (Mfn2) in regulating mitochondrial dynamics.
  • To explore the connection between Mfn2, mitochondria, and the endoplasmic reticulum in AD pathogenesis.
  • To highlight Mfn2 as a potential therapeutic target for AD and related disorders.

Main Methods:

  • Literature review of studies on Mfn2, mitochondrial dynamics, and Alzheimer's disease.
  • Analysis of research on the interplay between mitochondria and endoplasmic reticulum.
  • Synthesis of current understanding of Mfn2's function in cellular health and disease.

Main Results:

  • Mitofusin 2 (Mfn2) plays a key role in controlling mitochondrial morphology and network formation.
  • Mfn2 mediates communication between mitochondria and the endoplasmic reticulum, influencing cellular processes.
  • Dysregulation of Mfn2 is associated with mitochondrial dysfunction observed in Alzheimer's disease.

Conclusions:

  • Mfn2 is a critical regulator of mitochondrial dynamics and inter-organelle communication.
  • Understanding Mfn2's role in AD pathogenesis is vital for developing targeted therapies.
  • Further research into Mfn2 may unlock new strategies for treating neurodegenerative diseases linked to mitochondrial dysfunction.

Related Concept Videos

Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
19.3K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.3K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
11.7K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
708
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
16.5K